These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26560967)

  • 1. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
    Calo WA; Brewer NT
    Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papilloma virus vaccines and their role in cancer prevention.
    Jones RW; Coughlan EP; Reid JS; Sykes P; Watson PD; Cook C
    N Z Med J; 2007 Nov; 120(1266):U2829. PubMed ID: 18264198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2013 Aug; 31(37):3899-905. PubMed ID: 23820080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
    Goodman E; Reuschenbach M; Viering T; Luzak A; Greiner W; Hampl M; Jacob C
    Arch Gynecol Obstet; 2024 Nov; 310(5):2639-2646. PubMed ID: 39230793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact.
    Brotherton JM; Gertig DM
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):627-39. PubMed ID: 21819329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.
    Brisson M; Van de Velde N; De Wals P; Boily MC
    CMAJ; 2007 Aug; 177(5):464-8. PubMed ID: 17709404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Drolet M; Bénard É; Pérez N; Brisson M;
    Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?
    Jacob M; Bradley J; Barone MA
    Sex Transm Dis; 2005 Oct; 32(10):635-40. PubMed ID: 16205306
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus: clinical manifestations and prevention.
    Juckett G; Hartman-Adams H
    Am Fam Physician; 2010 Nov; 82(10):1209-13. PubMed ID: 21121531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective: Vaccinate boys too.
    Stanley M
    Nature; 2012 Aug; 488(7413):S10. PubMed ID: 22932433
    [No Abstract]   [Full Text] [Related]  

  • 13. [HPV vaccination in Germany Low vaccination rates endanger prevention goals].
    MMW Fortschr Med; 2009 Dec; 151(51-52):44-5. PubMed ID: 20088323
    [No Abstract]   [Full Text] [Related]  

  • 14. HPV vaccination--more answers, more questions.
    Sawaya GF; Smith-McCune K
    N Engl J Med; 2007 May; 356(19):1991-3. PubMed ID: 17494933
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV vaccines: their pathology-based discovery, benefits, and adverse effects.
    Nicol AF; de Andrade CV; Russomano FB; Rodrigues LS; Oliveira NS; Provance DW; Nuovo GJ
    Ann Diagn Pathol; 2015 Dec; 19(6):418-22. PubMed ID: 26321154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expected impact of a quadrivalent HPV vaccine in France].
    Riethmuller D; Prétet JL; Denis F; Aubin F; Pradat P; Clavel C; Dachez R; Gondry J; Carcopino X; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):389-95. PubMed ID: 19481365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HPV immunization on the detection of cervical disease.
    Munro AJ; Cruickshank ME
    Expert Rev Vaccines; 2014 Apr; 13(4):533-44. PubMed ID: 24606579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program.
    Quinn E; Donovan B; Sheppeard VK
    N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998
    [No Abstract]   [Full Text] [Related]  

  • 19. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
    Van de Velde N; Boily MC; Drolet M; Franco EL; Mayrand MH; Kliewer EV; Coutlée F; Laprise JF; Malagón T; Brisson M
    J Natl Cancer Inst; 2012 Nov; 104(22):1712-23. PubMed ID: 23104323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus and cancer of the cervix: a challenge facing Nepal.
    Gilbert DC
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):396-7. PubMed ID: 18603941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.